Literature DB >> 24813751

State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.

Kenan Omurtag1, Natalia M Grindler2, Kimberly A Roehl3, G Wright Bates4, Angeline N Beltsos5, Randall R Odem2, Emily S Jungheim2.   

Abstract

The aim of this study was to determine whether practice in states with infertility insurance mandates is associated with physician-reported practice patterns regarding hydrosalpinx management in assisted reproduction clinics. A cross-sectional, internet-based survey of 442 members of Society for Reproductive Endocrinology and Infertility or Society of Reproductive Surgeons was performed. Physicians practising in states without infertility insurance mandates were more likely to report performing diagnostic surgery after an inconclusive hysterosalpingogram than physicians practising in states with mandates (RR 1.2, 95% CI 1.1-1.3, P < 0.01). Additionally, respondents in states without mandates were more likely to report that, due to lack of infertility insurance coverage, they did not perform salpingectomy (SPX) or proximal tubal occlusion (PTO) before assisted reproduction treatment (RR 1.4, 95% CI 1.1-1.8, P = 0.01). Finally, respondents in states without mandates were less likely to report that the presence of assisted reproduction treatment coverage determined the urgency with which they pursued SPX or PTO before treatment (RR 0.7, 95% CI 0.5-1.0, NS). These results persisted after controlling for physician years in practice, age and clinic volume. In conclusion, self-reported physician practice interventions for hydrosalpinges before assisted reproduction treatment may be associated with state-mandated infertility insurance. Fallopian tube dysfunction is a known cause of infertility and severe dysfunction is manifested by dilation and occlusion, known as hydrosalpinx. Outcomes with assisted reproductive techniques (ART) are lower when hydrosalpinges are present and while there are several theories for this, reproductive specialist recommend "neutralizing" the tube either by occlusion or removal in order to enhance pregnancy rates. In the United States, coverage for infertility services is not uniform with only 15 states having some legislation requiring infertility benefits. Some states where ART is covered liberally, physicians might have different practice patterns related to the neutralization of hydrosalpinges compared to those who are in non -mandated states. We utilized a survey of over 400 providers in the United States to examine their practice patterns as it relates to hydrosalpinges based on which state they practice in and whether or not that state has mandated coverage of not.
Copyright © 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  assisted reproduction treatment; hydrosalpinx; insurance coverage; mandate; salpingectomy

Mesh:

Year:  2014        PMID: 24813751      PMCID: PMC4114072          DOI: 10.1016/j.rbmo.2014.03.007

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  26 in total

1.  How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; Gordon Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Fertil Steril       Date:  2012-03-09       Impact factor: 7.329

2.  Insurance coverage and outcomes of in vitro fertilization.

Authors:  Tarun Jain; Bernard L Harlow; Mark D Hornstein
Journal:  N Engl J Med       Date:  2002-08-29       Impact factor: 91.245

3.  Risk factors for regret after tubal sterilization: 5 years of follow-up in a prospective study.

Authors:  L S Wilcox; S Y Chu; E D Eaker; S L Zeger; H B Peterson
Journal:  Fertil Steril       Date:  1991-05       Impact factor: 7.329

Review 4.  Hysterosalpingography in the 1990s.

Authors:  I C Yoder; D A Hall
Journal:  AJR Am J Roentgenol       Date:  1991-10       Impact factor: 3.959

Review 5.  Hydrosalpinx affects the implantation of previously cryopreserved embryos.

Authors:  M A Akman; J E Garcia; M D Damewood; L D Watts; E Katz
Journal:  Hum Reprod       Date:  1996-05       Impact factor: 6.918

6.  Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature.

Authors:  J Vandromme; E Chasse; B Lejeune; M Van Rysselberge; A Delvigne; F Leroy
Journal:  Hum Reprod       Date:  1995-03       Impact factor: 6.918

7.  Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization.

Authors:  E Katz; M A Akman; M D Damewood; J E García
Journal:  Fertil Steril       Date:  1996-07       Impact factor: 7.329

8.  Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization.

Authors:  M Kassabji; J A Sims; L Butler; S J Muasher
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1994-08       Impact factor: 2.435

9.  Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography.

Authors:  A N Andersen; Z Yue; F J Meng; K Petersen
Journal:  Hum Reprod       Date:  1994-10       Impact factor: 6.918

10.  Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx.

Authors:  C Fleming; M G Hull
Journal:  Br J Obstet Gynaecol       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.